Breaking News

Kenox Expands Capabilities to Support GLP Pre-Clinical Studies

Adds a cleanroom and small-scale non-sterile GMP capabilities.

Author Image

By: Charlie Sternberg

Associate Editor

Kenox Pharmaceuticals Inc., a company dedicated to developing innovative Orally Inhaled and Nasal Drug Products (OINDPs), has added small-scale non-sterile GMP capabilities to support GLP pre-clinical studies to its suite of drug development services. This strategic expansion underscores Kenox’s commitment to accelerating the journey from molecule to clinic, providing its partners with the tools and expertise needed to bring life-changing therapies to market faster. The new capabilit...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters